WAWiku Andonotopo

Wiku Andonotopo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wiku Andonotopo has a total of 131 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Transplanted Decidua–Placenta Axis in Human Uterus Transplantation: Integrating Ischemia–Reperfusion Injury, Alloimmune Surveillance, and Cervicovascular Remodeling to Explain Preeclampsia, Prematurity, and Live Birth

    by Wiku Andonotopo, I Nyoman Hariyasa Sanjaya, Muhammad Adrianes Bachnas, Wisnu Prabowo, Eric Edwin Yuliantara, Efendi Lukas, Julian Dewantiningrum, Mochammad Besari Adi Pramono, Anak Agung Gede Putra Wiradnyana, Anak Agung Ngurah Jaya Kusuma, et al.

    Objective: Pregnancy following uterus transplantation (UTx) has moved beyond proof-of-concept, yet consistently exhibits a high-risk obstetric profile that remains insufficiently explained. This review aimed to examine whether these outcomes can be understood through a unified mechanistic framework, conceptualized here as the transplanted decidua–placenta axis, linking graft biology with placental development and clinical phenotype.Methods: A structured literature review was conducted across PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane Library from inception to the most recent update. Studies were selected based on predefined inclusion criteria focusing on human UTx outcomes, graft pathology, placental biology, and immunological mechanisms. Screening and eligibility assessment were performed independently, with discrepancies resolved by consensus. Data were synthesized qualitatively, integrating clinical, experimental, and mechanistic evidence rather than pursuing meta-analysis, given heterogeneity across study designs.Results: From 1,322 records identified, 25 studies were included following systematic screening. Across these, a recurring pattern emerged—UTx pregnancies appear shaped by pre-pregnancy graft injury, including ischemia–reperfusion damage and subclinical rejection, followed by a superimposed dual alloimmune interface during gestation. This sequence seems to influence decidualization, disrupt spiral artery remodeling, and constrain trophoblast invasion. Clinically, these mechanisms converge on a phenotype characterized by hypertensive disorders, fetal growth restriction, abnormal placentation, and prematurity. Notably, evidence remains fragmented, often indirect, yet increasingly convergent.Conclusion: UTx pregnancy may represent a distinct model of placental dysfunction rather than a conventional gestation under immunosuppression. Recognizing this shift has implications for surveillance, biomarker development, and future research—although, at present, much still rests on inference rather than direct proof.Sumbu Desidua–Plasenta pada Transplantasi Uterus Manusia: Integrasi Cedera Iskemia–Reperfusi, Surveilans Aloimun, serta Remodeling Servikovaskular sebagai Mekanisme yang Menjelaskan Preeklamsia, Prematuritas, dan Keberhasilan Kelahiran HidupAbstrakTujuan: Kehamilan setelah transplantasi uterus (UTx) telah melampaui tahap pembuktian konsep, namun secara konsisten menunjukkan profil obstetri berisiko tinggi yang hingga kini belum sepenuhnya dapat dijelaskan. Tinjauan ini bertujuan untuk mengkaji apakah luaran tersebut dapat dipahami melalui suatu kerangka mekanistik terpadu, yang dalam tinjauan ini dikonseptualisasikan sebagai transplanted decidua–placenta axis, yang menghubungkan biologi graft dengan perkembangan plasenta dan fenotipe klinis.Metode: Tinjauan literatur terstruktur dilakukan melalui basis data PubMed/MEDLINE, Embase, Scopus, Web of Science, dan Cochrane Library sejak awal publikasi hingga pembaruan terkini. Studi dipilih berdasarkan kriteria inklusi yang telah ditetapkan sebelumnya, dengan fokus pada luaran klinis UTx pada manusia, patologi graft, biologi plasenta, serta mekanisme imunologis. Proses penyaringan dan penilaian kelayakan dilakukan secara independen, dengan penyelesaian perbedaan melalui konsensus. Sintesis data dilakukan secara kualitatif dengan mengintegrasikan bukti klinis, eksperimental, dan mekanistik, tanpa meta-analisis mengingat heterogenitas desain studi.Hasil: Dari 1.322 rekaman yang teridentifikasi, sebanyak 25 studi dimasukkan setelah proses seleksi sistematis. Secara konsisten, ditemukan pola bahwa kehamilan UTx tampaknya dipengaruhi oleh cedera graft pra-kehamilan, termasuk kerusakan akibat iskemia–reperfusi dan rejeksi subklinis, yang kemudian diikuti oleh adanya paparan alloimun ganda selama gestasi. Rangkaian proses ini diduga memengaruhi desidualisasi, mengganggu remodeling arteri spiralis, serta membatasi invasi trofoblas. Secara klinis, mekanisme tersebut berkonvergensi menjadi suatu fenotipe yang ditandai oleh gangguan hipertensi kehamilan, restriksi pertumbuhan janin, abnormalitas implantasi plasenta, serta prematuritas. Bukti yang tersedia masih terfragmentasi dan sebagian bersifat tidak langsung, namun menunjukkan kecenderungan konvergen.Kesimpulan: Kehamilan pada UTx kemungkinan merepresentasikan suatu model disfungsi plasenta yang berbeda, bukan sekadar kehamilan konvensional dalam kondisi imunosupresi. Pergeseran paradigma ini memiliki implikasi terhadap strategi surveilans, pengembangan biomarker, serta arah penelitian ke depan—meskipun hingga saat ini sebagian besar kesimpulan masih bersifat inferensial dan belum sepenuhnya terkonfirmasi secara langsung.

  • Environmental Exposures and Placental Dysfunction in Pregnancy: A Systematic Review and Mechanistic Synthesis of Microplastics, Per- and Polyfluoroalkyl Substances, Phthalates, Heat Stress, and Air Pollution

    by Roland Frederik Lengkey, Aloysius Suryawan, Wiku Andonotopo, Ridwan Abdullah Putra, Theresia Monica Rahardjo, Rizna Tyrani Rumanti, Julia Windi Gunadi, Arief Setiawan, Muhammad Adrianes Bachnas, Mochammad Besari Adi Pramono, et al.

    Environmental exposures during pregnancy may affect placental function, yet evidence remains dispersed across separate literatures on particles, persistent chemicals, consumer-product toxicants, air pollution, and climate-related heat. This Preferred Reporting Items for Systematic Reviews and Meta-analyses 2020–guided systematic review with mechanistic synthesis examined associations of microplastics/nanoplastics, per- and polyfluoroalkyl substances (PFAS), phthalates, air pollution, and heat stress with placental pathways and adverse pregnancy outcomes. PubMed/MEDLINE, PubMed Central, Scopus, Web of Science, Embase, and the Cochrane Library were searched for English-language studies published from January 2010 to March 31, 2026. Thirty-five studies met eligibility criteria, comprising human observational studies, placental analytical investigations, systematic reviews/meta-analyses, and mechanistic or conceptual reviews. Given substantial heterogeneity in study design, exposure assessment, placental endpoints, and outcome definitions, evidence was synthesized qualitatively rather than pooled statistically, with findings interpreted according to evidence type, directness, and methodological limitations. Associations were most consistent for heat exposure with adverse birth outcomes, PFAS with hypertensive and metabolic pregnancy outcomes, and phthalates with placental endocrine alterations and preterm birth-related outcomes. For microplastics, direct placental detection and translocation evidence was more developed than evidence linking exposure to clinical outcomes. Across domains, oxidative stress, inflammation, endocrine/metabolic disruption, epigenetic programming, and vascular dysfunction emerged as recurrent candidate pathways. These convergent mechanisms support biological plausibility but do not establish causality or multi-exposure synergy. Most studies evaluated single exposure domains, and direct multi-exposure placental evidence remains limited. This review represents a preliminary evidence-mapping step by the contributors to consolidate available data, identify methodological gaps, and guide subsequent longitudinal, placenta-focused, multi-exposure research and prospective data collection.

  • Open Access

    Neuro-ophthalmic Complications of Pregnancy and the Postpartum Period: A Systematic Review of Pathophysiology, Diagnosis, and Clinical Outcomes

    by Wiku Andonotopo, Muhammad A. Bachnas, Mochammad B. A. Pramono, Julian Dewantiningrum, I Nyoman H. Sanjaya, Dudy Aldiansyah, Aloysius Suryawan, Ridwan A. Putra, Theresia M. Rahardjo, Waskita E. K. Andanaputra

    Neuro-ophthalmic complications during pregnancy and the postpartum period are uncommon but clinically important because visual symptoms may be the first indication of neurological, vascular, hypertensive, or endocrine disease. This systematic review evaluated the pathophysiology, diagnostic features, management considerations, and reported clinical outcomes of pregnancy-related neuro-ophthalmic disorders. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidance, databases and registers were searched from January 1980 through December 2025. Of 540 records identified, 360 remained after prescreening removal, 112 reports were sought for retrieval, and 103 underwent full-text eligibility assessment; 37 publications were included in the qualitative synthesis. The evidence comprised heterogeneous observational studies, case series, case reports, systematic and narrative reviews, and clinical guidance, precluding meaningful quantitative pooling. Idiopathic intracranial hypertension, cerebral venous sinus thrombosis, posterior reversible encephalopathy syndrome, pituitary disorders, and optic neuritis/neuromyelitis optica spectrum disorder represented the principal clinical domains. Across these conditions, raised intracranial pressure, venous outflow impairment, endothelial dysfunction, sellar or optic-pathway compression, and inflammatory demyelination emerged as recurring, sometimes overlapping mechanisms. Reported visual outcomes ranged from recovery to persistent visual impairment, although outcome definitions and follow-up were inconsistent and much of the pregnancy-specific evidence remained observational or case-based. The reviewed literature therefore suggests physiological overlap rather than establishing a single unified mechanism. Current evidence supports prompt recognition, disorder-specific investigation, and multidisciplinary management, while prospective studies with standardised visual and maternal outcomes are needed to define prognosis and strengthen pregnancy-specific recommendations.

  • The Mosaic Placenta: Somatic Genomic Variation as a Hidden Driver of Placental Dysfunction and Adverse Pregnancy Outcomes—A Systematic Review and Translational Framework for Precision Maternal–Fetal Medicine

    by Wiku Andonotopo, Aloysius Suryawan, Ridwan Abdullah Putra, Theresia Monica Rahardjo, Roland Frederik Lengkey, Rizna Tyrani Rumanti, Arief Setiawan, Glen Marion Mose, Frenki Pieter Hetharia, Benny Hasan Purwara, et al.

  • Open Access

    Maternal Diabetic Cardiomyopathy and Fetal Consequences: Reframing Pregnancy with Diabetes as a Maternal–Placental–Fetal Cardiovascular Syndrome Integrating Myocardial Strain, Continuous Glucose Monitoring, and Placental–Fetal Perfusion

    by Aloysius Suryawan, Wiku Andonotopo, Theresia Monica Rahardjo, Julia Windi Gunadi, Diana Krisanti Jasaputra, Ridwan Abdullah Putra, Rizna Tyrani Rumanti, Roland Frederik Lengkey, Muhammad Adrianes Bachnas, Mochammad Besari Adi Pramono, et al.

    Maternal diabetes has traditionally been approached as a metabolic disorder of pregnancy, yet its cardiovascular dimensions particularly on the maternal side remain insufficiently integrated into fetal risk assessment. Over the past decade, advances in myocardial deformation imaging, continuous glucose monitoring (CGM), and placental Doppler interrogation have expanded the capacity to interrogate maternal–fetal physiology, although these domains have largely progressed in parallel rather than in synthesis. In this systematic review, conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidance, we identified and integrated evidence from 32 studies examining subclinical maternal myocardial dysfunction, CGM-derived glycemic exposure, placental–fetoplacental perfusion, and fetal cardiac structure and function in pregnancy with diabetes. Across heterogeneous populations and methodologies, a recurrent pattern emerged. Even in the absence of overt cardiomyopathy or reduced ejection fraction, subtle impairment in maternal myocardial strain, often accompanied by increased glycemic variability despite acceptable glycated hemoglobin (HbA1c) was consistently associated with altered placental perfusion and early fetal cardiac remodeling. Placental maladaptation appeared not merely secondary, but functionally intermediary, linking maternal cardiometabolic stress to fetal hemodynamic changes and myocardial adaptation. Notably, CGM-derived metrics, particularly glycemic variability and time outside target range, appeared more closely aligned with cardiovascular alterations than HbA1c alone. Fetal cardiac changes were frequently detectable before clinical compromise, suggesting that current surveillance strategies may underestimate early risk. While causality cannot be established, the convergence of findings across domains supports a more integrated interpretation. These observations support reframing pregnancy with diabetes as a maternal–placental–fetal cardiovascular syndrome rather than a purely metabolic disorder. This perspective may inform future risk stratification and underscores the need for longitudinal and mechanistically integrated studies.

  • Open Access

    Precision Perinatology of Moringa oleifera Lam. in Pregnancy: Trimester-specific Pharmacokinetics, Placental Transfer Biology, and Clinically Actionable Drug-supplement Interaction Risk – A Systematic Review and Translational Synthesis

    by Wiku Andonotopo, Dhika Prabu Armadhanu, Mochammad Besari Adi Pramono, Julian Dewantiningrum, Muhammad Adrianes Bachnas, Wisnu Prabowo, I Nyoman Hariyasa Sanjaya, Anak Agung Gede Putra Wiradnyana, Anak Agung Ngurah Jaya Kusuma, Khanisyah Erza Gumilar, et al.

    The clinical use of botanical supplements during pregnancy is often guided more by tradition than by pharmacologic certainty, and Moringa oleifera Lam. is no exception. Despite expanding interest in its antioxidant, metabolic, and nutritional properties, no prior synthesis has systematically integrated trimester-specific maternal physiology, placental transport biology, and clinically relevant drug-supplement interaction risk within a precision perinatology framework. We conducted a systematic review in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines to examine the pharmacokinetic, mechanistic, placental, and interaction literature relevant to M. oleifera in maternal–fetal medicine. Comprehensive searches of biomedical databases and reference lists identified 1320 records; after duplicate removal and eligibility assessment, 47 studies met predefined inclusion criteria. Risk of bias was appraised using design-appropriate tools. Evidence was grouped into mechanistic domains: maternal absorption–distribution–metabolism–excretion remodeling, placental transporter systems, physiologically based pharmacokinetic (PBPK) modeling, and clinical interaction signals. Across heterogeneous designs, signals emerged for cytochrome P450 3A4 modulation, phase II pathway involvement, absorption interference related to fiber-rich preparations, and measurable pharmacokinetic interaction in nonpregnant adults. Parallel literature documents trimester-dependent shifts in enzyme activity, renal clearance, plasma volume, protein binding, and placental transporter regulation – variables that plausibly alter both maternal exposure and fetal transfer. Direct pregnancy-specific pharmacokinetic data for Moringa are absent, and no study has quantified fetal exposure. We therefore propose a multiscale translational model linking molecular bioactives to maternal absorption, distribution, metabolism, and excretion remodeling, placental flux, and clinically actionable risk stratification. The findings underscore a critical gap between widespread use and mechanistic certainty, and call for trimester-resolved pharmacokinetic, placental perfusion, and PBPK validation studies before routine perinatal integration.

  • Open Access

    From Placental Dysfunction to Lifelong Cardiovascular–Renal Disease: A Systematic Review of Multiomics Biomarkers and Postpartum Risk Stratification after Preeclampsia and Fetal Growth Restriction

    by Wiku Andonotopo, Muhammad Adrianes Bachnas, Mochammad Besari Adi Pramono, Julian Dewantiningrum, I. Nyoman Hariyasa Sanjaya, Dudy Aldiansyah, Arief Setiawan, Aloysius Suryawan, Ridwan Abdullah Putra, Theresia Monica Rahardjo, et al.

    Placental dysfunction has traditionally been regarded as a pregnancy-specific disorder; however, growing evidence suggests its implications extend well beyond the perinatal period. This systematic review aimed to synthesize current evidence linking preeclampsia and fetal growth restriction to long-term maternal cardiovascular and renal outcomes, and to examine the potential contribution of emerging biomarkers and multiomics approaches to risk assessment. The review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 principles. A comprehensive search of PubMed/MEDLINE, PubMed Central, Embase, Scopus, Web of Science, and the Cochrane Library identified 42 eligible studies published between 2000 and 2025. Included studies encompassed systematic reviews, meta-analyses, nationwide cohort studies, diagnostic investigations, and molecular profiling research. The evidence consistently demonstrated that placental dysfunction is associated with persistent cardiovascular and renal vulnerability after pregnancy. Women with a history of preeclampsia or fetal growth restriction showed increased risks of hypertension, coronary artery disease, stroke, heart failure, chronic kidney disease, and end-stage kidney disease during long-term follow-up. Mechanistically, abnormal placentation was linked to angiogenic imbalance, endothelial dysfunction, inflammation, and oxidative stress, providing a biological basis for these associations. Emerging multiomics platforms, including transcriptomics, metabolomics, proteomics, and cell-free RNA profiling, further revealed molecular heterogeneity and showed promise for earlier identification of women at increased risk. The findings support a life-course perspective in which placental dysfunction functions as an early indicator of future cardiovascular and renal disease rather than a complication confined to pregnancy. Integration of clinical characteristics with validated biomarker and multiomics data may enhance postpartum risk stratification and support more individualized preventive strategies.

  • Open Access

    Cumulative fetal radiation dose in pregnant oncology patients: Reevaluating risk beyond single-exposure thresholds

    by Wiku Andonotopo, Muhammad Adrianes Bachnas, Mochammad Besari Adi Pramono, Julian Dewantiningrum, Efendi Lukas, I. Nyoman Hariyasa Sanjaya, Anak Agung Gede Putra Wiradnyana, Anak Agung Ngurah Jaya Kusuma, Khanisyah Erza Gumilar, Ernawati Darmawan, et al.

    This systematic review examines how fetal radiation risk is currently understood in pregnant patients undergoing oncologic imaging and treatment, and where that understanding begins to fall short. Clinical decisions are still often framed around single-exposure thresholds, yet real care rarely occurs in isolated steps. We searched PubMed/MEDLINE, PubMed Central, Scopus, Web of Science, and the Cochrane Library for studies published between 2000 and 2025, using predefined eligibility criteria focused on pregnancy, ionizing radiation, and oncology-related exposures. Two reviewers independently screened records, assessed full texts, and extracted data, with disagreements resolved through discussion. Thirty-two studies were included, encompassing clinical observations, dosimetric analyses, and computational modeling. Across these studies, fetal dose estimates varied widely depending on modality, technical factors, and gestational timing. Individual procedures – computed tomography (CT), positron emission tomography/CT, or radiotherapy scatter – often remained below traditional safety thresholds, but a different pattern emerged when exposures were considered sequentially. The cumulative burden, especially when distributed across sensitive developmental windows, appeared less predictable and not fully captured by existing models. Radiobiological responses also shifted with gestational stage, which complicates any attempt to define a universal threshold. The evidence is uneven in places, and much of it relies on modeling rather than direct clinical measurement. Still, a consistent signal appears: risk is not static, and it does not accumulate in a simple linear way. This review brings these elements together and proposes a more integrated perspective. Future work will need to move beyond isolated dose estimates and toward frameworks that reflect how care actually unfolds.

  • Open Access

    Graphicflow ultrasound in fetal echocardiography: principles, hemodynamics, clinical applications, and future perspectives

    by Wiku Andonotopo, Muhammad Adrianes Bachnas, Mochammad Besari Adi Pramono, Julian Dewantiningrum, Aloysius Suryawan, Ridwan Abdullah Putra, I Nyoman Hariyasa Sanjaya, Dudy Aldiansyah, Efendi Lukas, Nuswil Bernolian, et al.

    Background: Graphicflow is a commercially available ultrasound technology that uses trajectory-based blood speckle tracking to display intracardiac blood-cell movement in real time during fetal echocardiography. Unlike conventional Doppler ultrasound, which mainly measures blood-flow velocity and direction, this technique offers an additional perspective by revealing how blood moves, circulates, and organizes within the fetal heart. Although interest in this approach has grown over recent years, the current evidence remains limited and is largely based on early feasibility studies and small observational reports. Content: This illustrated Opinion Paper brings together the available evidence on trajectory-based fetal hemodynamic imaging by reviewing published fetal, neonatal, and pediatric blood speckle-tracking studies alongside international fetal echocardiography guidelines, technical reports, and established principles of cardiovascular fluid dynamics. We discuss the underlying physics of blood speckle tracking, the physiological significance of intracardiac flow patterns, potential clinical applications, existing technical challenges, and key considerations for responsible clinical adoption. We also include original fetal imaging examples and conceptual illustrations to summarize current knowledge while highlighting important gaps that require further investigation. Given the limited clinical validation currently available, this review should be viewed as an evidence-informed synthesis and a framework for generating future research hypotheses rather than evidence supporting routine clinical use. Summary: Current evidence suggests that trajectory-based blood-flow imaging may complement conventional fetal echocardiography by providing qualitative visualization of intracardiac flow organization beyond velocity mapping alone. However, standardized acquisition protocols, quantitative hemodynamic metrics, reproducibility, gestational age-specific normative datasets, and prospective multicenter validation remain necessary before routine clinical implementation can be recommended. Outlook: Future research should prioritize methodological standardization, rigorous clinical validation, and demonstration of incremental clinical value beyond conventional fetal echocardiography to support the responsible integration of trajectory-based fetal hemodynamic imaging into clinical practice.

  • Open Access

    Decoding Immune-checkpoint Dynamics and Microchimerism in Autoimmune Pregnancy: Systematic Review and Federated Causal Multi-omic Synthesis to Predict and Prevent Adverse Outcomes

    by Wiku Andonotopo, Muhammad Adrianes Bachnas, Wisnu Prabowo, Julian Dewantiningrum, Mochammad Besari Adi Pramono, Khanisyah Erza Gumilar, Muhammad Ilham Aldika Akbar, Ernawati Darmawan, I Nyoman Hariyasa Sanjaya, Anak Agung Gede Putra Wiradnyana, et al.

    A BSTRACT: Autoimmune pregnancy lies at a complex intersection of maternal immune tolerance and persistent autoimmunity, where small perturbations can have outsized clinical consequences. Rather than functioning as a static state, immune adaptation in pregnancy appears to evolve through dynamic interactions between immune-checkpoint pathways and bidirectional fetal-maternal microchimerism. This systematic review, conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines, synthesizes cross-disease evidence linking immune-checkpoint regulation (programmed cell death protein 1/programmed death-ligand 1, cytotoxic T-lymphocyte antigen-4, T cell immunoglobulin and mucin domain-containing protein 3, LAG-3 (Lymphocyte-activation gene 3), and human leukocyte antigen G with microchimeric cell persistence in autoimmune pregnancy. Comprehensive searches of PubMed, Scopus, and Embase identified 1720 records; 36 studies met predefined inclusion criteria, with 20 prioritized for core synthesis following structured risk-of-bias assessment using ROBIS, risk of bias in non-randomized studies—of interventions (ROBINS-I), and a measurement tool to assess systematic reviews 2. Included evidence spans mechanistic experiments, placental pathology, human cohort studies, and pharmacovigilance analyses, primarily in systemic lupus erythematosus, rheumatoid arthritis, autoimmune thyroid disease, and preeclampsia. Across studies, immune-checkpoint dysregulation at the maternal–fetal interface is consistently associated with impaired tolerance, while persistent fetal or maternal microchimeric cells appear to shape immune memory, postpartum autoimmune activity, and offspring immune programming. Beyond summarizing existing evidence, this review integrates findings into six mechanistic themes and proposes a conceptual, translational framework in which multi-omic profiling and causal inference could be applied to study checkpoint–microchimerism interactions across diseases. This framework is explicitly hypothesis-generating and not presented as a validated clinical model, but rather as a research blueprint to guide future longitudinal studies. By clearly distinguishing established evidence from forward-looking synthesis, this review reframes autoimmune pregnancy as a dynamic immune system with implications for risk stratification, monitoring, and the future development of precision approaches in perinatal immunology.